Bisphosphonate-containing vaccine pharmaceutical composition for humoral immunity
US10471141B2 · kind B2 · utility
1Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2015 |
| Grant date | Nov 12, 2019 |
| Priority date | — |
| Expiry date | Sep 2, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention aims to provide a vaccine pharmaceutical composition universally usable for induction of humoral immunity against various antigens and exerting a high antibody production inducing effect. The present invention relates to a vaccine pharmaceutical composition for inducing humoral immunity, including: an antigen; and an immunity induction promoter that is a bisphosphonate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.